• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Pancreatic-biliary tract cancer treatment with an anti-tumor T cell activation through inhibition of tumor-promoting macrophages

Research Project

Project/Area Number 15K19866
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Digestive surgery
Research InstitutionHirosaki University

Principal Investigator

Miura Takuya  弘前大学, 医学部附属病院, 講師 (30722136)

Project Period (FY) 2015-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords腫瘍促進TAM / 抗腫瘍T細胞 / TLR3 / TLR9 / 腫瘍免疫
Outline of Final Research Achievements

In the patients with extrahepatic bile duct cancer, the histopathological analysis demonstrated high infiltration of tumor-promoting macrophages and low infiltration of tumor-killing T-cells have a poor prognostic impact. In vitro research was conducted on pancreatic and biliary cancer, but the prospect of the experimental design was out of order. Considering feasible research from the cooperation system in our institution, we focused on TLR3. Tumor cells are known to undergo necrosis due to external stress such as chemotherapy and radiation therapy. In this situation, endogenous factors called DAMPs are thought to work in tumor promotion or suppression via TLR3 in tumor microenvironment. In this research, TLR3 expression in tumor cells is associated with lymph node metastasis and induces expression of CCL2, CCL5, and IL-8. Tumor cell expression of TLR3 is suggested to affect surrounding microenvironment and to be related to metastatic potential.

Academic Significance and Societal Importance of the Research Achievements

腫瘍促進TAMを標的とし、抗腫瘍T細胞浸潤を調節することで予後の改善が期待できることを示唆した一方、TLR3という免疫機構に関連するシステムが腫瘍細胞に存在し、それが腫瘍微小環境に影響を与え、腫瘍の進展に寄与することを示唆したことが研究成果である。この知見は、宿主に存在する免疫機構の中心的存在であるマクロファージやT細胞を標的とする場合、それらの免疫機構を調節することは、腫瘍細胞にも影響を及ぼす事実を示している。腫瘍免疫の複雑系を示唆し、微小環境を標的とする際、腫瘍細胞自体にも着目する必要があることを示したことに社会的意義がある。

Report

(5 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (3 results)

All 2019 2017 2015

All Journal Article (1 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results,  Open Access: 1 results) Presentation (2 results)

  • [Journal Article] Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer.2017

    • Author(s)
      Miura T, Yoshizawa T, Hirai H, Seino H, Morohashi S, Wu Y, Wakiya T, Kimura N, Kudo D, Ishido K, Toyoki Y, Kijima H, Hakamada K.
    • Journal Title

      Anticancer Res

      Volume: 37 Issue: 1 Pages: 183-190

    • DOI

      10.21873/anticanres.11304

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] Toll like receptor 3は大腸癌の進展に関与する2019

    • Author(s)
      吉田 達哉、三浦 卓也、坂本 義之、諸橋 一、黒瀬 顕、今泉 忠淳、袴田 健一
    • Organizer
      第119回日本外科学会定期学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] CD163陽性M2マクロファージの腫瘍間質浸潤とCD8陽性T細胞の癌細胞巣浸潤は浸潤性肝外胆管癌の予後因子となる2015

    • Author(s)
      三浦卓也、吉澤忠司、木村憲央、工藤大輔、石戸圭之輔、豊木嘉一、袴田健一、鬼島宏
    • Organizer
      第115回日本外科学会定期学術集会
    • Place of Presentation
      名古屋国際会議場(愛知県名古屋市)
    • Year and Date
      2015-04-18
    • Related Report
      2015 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi